School of Medicine
Showing 1-100 of 227 Results
-
Kristen Aiemjoy
Postdoctoral Research Fellow, Infectious Diseases
Bio Dr. Aiemjoy is an infectious disease epidemiologist with interests in diarrheal disease, measurement, diagnostics, and sero-epidemiology. She is currently working on evaluating serological markers for Salmonella Typhi and Paratyphi infection as part of the Sero-Epidemiology and Environmental Surveillance (SEES) study in Nepal, Pakistan and Bangladesh.
-
Md Khadem Ali
Postdoctoral Research Fellow, Pulmonary and Critical Care Medicine
Current Research and Scholarly Interests Pulmonary vascular remodeling, airway and lung remodeling, lung fibrosis
-
Ronan Arthur
Postdoctoral Research Fellow, Infectious Diseases
Bio How does a changing epidemic landscape impact people's perceptions of risk and their behavior? How might these changes impact disease dynamics? These questions are more complex than they seem because they involve endogenous, interacting elements in a system.
Ronan studies the interaction between the environment, infectious disease dynamics, and human behavior change. He utilizes techniques from geography and global health in empirical work on Ebola Virus Disease in Liberia. He also utilizes mathematical biology.and nonlinear dynamics tools to model these interacting complex systems. -
Ewa Bielczyk Maczynska
Postdoctoral Research Fellow, Cardiovascular Medicine
Current Research and Scholarly Interests regulation of adipocyte differentiation, fibrosis, TGF-beta signaling
-
Arianna Celis Luna
Postdoctoral Research Fellow, Infectious Diseases
Bio Arianna I. Celis Luna is a postdoctoral fellow in the lab of Dr. David Relman. Her research will investigate the role of the GI microbiome on iron absorption during pregnancy. She aims is to elucidate a functional role for the microbiome during this critical time period by combining metatranscriptomic and metametabolomic data from in vivo samples with biochemical data from in vitro samples. She hopes to shed light on how iron-deficiency anemia, still affecting ~50% of pregnant women in developed countries, can be more efficiently treated or prevented.
Arianna received her Ph.D. in Biochemistry from Montana State University in 2018. She worked in the lab of Dr. Jennifer DuBois where her research focused on how, at the molecular level, bacteria build iron into the versatile molecule known as heme and break it apart again. Her work examined how these reactions are critical for both pathogenic species, such as Staphylococcus aureus, and the resident bacteria of the digestive tract.
Arianna?s work encompasses 6 published papers in journals like the Journal of the American Chemical Society, the Journal of Biological Chemistry, and ACS Biochemistry. She has presented her work in several conferences, including Gordon Research Conferences and the ASBMB Annual Meeting, and at Montana State University as part of the Kopriva Science Seminar Series after receiving the Kopriva Graduate Student Fellowship. -
Jean Coquet
Postdoctoral Research Fellow, Biomedical Informatics
Bio I received my PhD from University of Rennes 1, where I was working in the Dyliss team (DYnamics, Logics and Inference for biological Systems and Sequences), at the INRIA institute (Rennes, France). My research area have focused on making sense of unconventional and complex wide data biological sets, such as signaling pathways, gene interactions, or more recently, Electronical Health Records (EHRs). In Boussard Lab, my research is to establish different novel strategies for the evaluation the quality healthcare delivery, involving machine learning and Natural Language Processing (NLP) methods.
-
Anthony Crimarco
Postdoctoral Research Fellow, SCRDP/ Heart Disease Prevention
Bio Anthony Crimarco, Ph.D., is a Postdoctoral Fellow in Cardiovascular Disease Prevention at the Stanford Prevention Research Center. His primary research interests include diet and lifestyle interventions. More specifically he focuses on the health benefits of plant-based diets, the impact of the built environment on diet and physical activity behaviors, and the use of mHealth and eHealth in lifestyle interventions.
Dr. Crimarco completed a Ph.D. in Health Promotion, Education, and Behavior from the Arnold School of Public Health at the University of South Carolina in 2019. He also completed M.S. degrees in Management at the University of Florida (2013) and Wellness Management at Ball State University (2012). -
Kathleen Dantzler
Postdoctoral Research Fellow, Infectious Diseases
Bio Throughout my scientific training, I have focused on building an interdisciplinary background in molecular parasitology, biochemistry, immunology, and public health to provide me with the skills needed to pursue development of a successful malaria vaccine. My PhD research at Harvard centered on understanding immune responses to the developing transmission stages of malaria. By providing the first evidence for natural immunity to immature transmission stages, this work supports interrupting development and maturation of these parasites as a novel approach to transmission-blocking vaccine design. During my postdoctoral fellowship and in the future, I hope to continue researching host-pathogen interactions with applications to malaria vaccine development, while also being involved in global health work in the field. Currently my work focuses on understanding mechanisms of natural immunity to malaria and immune tolerance, particularly in the context of gamma delta T cell and monocyte responses.
-
Weiguo Fan
Postdoctoral Research Fellow, Gastroenterology
Bio My research focuses on liver diseases. I got my Ph.D. degree in virology and immune response at Institut Pasteur of Shanghai, Chinese Academy of Sciences. The two main projects during my Ph.D. program are: 1) explore the relationship between the immune response in Hepatitis C virus infection and Interferon treatment; and 2) investigate the function of ECM1 in liver fibrosis. As a postdoc in Stanford, I will try to integrate basic and translational liver research and focus on: 1) investigate molecular functions of liver immune cells in liver disease; 2) explore key factors determining the change of liver microenvironment that cause liver diseases; 3) use new techniques, such as next-generation sequencing, RNAseq or signal cell sequencing, to explore key factors affecting liver disease and treatment in patients.
-
Jacqueline Ferguson
Postdoctoral Research Fellow, General Internal Medicine
Bio Dr. Jacqueline Ferguson is a postdoctoral research fellow working with Dr. David Rehkopf at the Center for Population Health Sciences at Stanford and Dr. Donna Zulman through the Big Data-Scientist Training Enhancement Program (BD-STEP) at the Palo Alto VA (Veterans Health Administration).
She specializes in using secondary data sources such as occupational records, insurance claims, and electronic health records to study the relationship between environmental, social exposures and population health. Her research interests are widespread, but all center around methodology to handle time-varying exposures affected by prior exposure and methodology to account for multiple co-exposures or exposure mixtures.
Jacqueline?s doctoral research examined the impact of specific components of shift work on worker health, and identified night and rotational work as risk factors for hypertension and Type II diabetes. As a postdoc and BD-STEP fellow, Jacqueline is applying methodology, primarily developed for assessing chemical mixtures in environmental epidemiology, to examine co-occurring social determinants of health. Her research seeks to understand how multiple social determinants of health can simultaneously influence Veteran care and health within the Veterans Health Administration. -
Priya Fielding-Singh
Postdoctoral Research Fellow, SCRDP/ Heart Disease Prevention
Bio I am a Sociologist and Postdoctoral Fellow in Cardiovascular Disease Prevention at the Stanford Prevention Research Center. My research examines health, gender, and social inequality.
My primary research agenda investigates health disparities across class, race, and gender in the United States. I draw on both qualitative and quantitative methods to understand how neighborhoods, schools, and families shape our health behaviors and outcomes. My work has been published in journals such as Social Science & Medicine, Obesity, Sociological Science, and the Journal of Adolescent Health.
I hold a Ph.D. in Sociology from Stanford University, a M.A. in Anthropology from the University of Bremen, and a B.S. in Education and Social Policy from Northwestern University. -
Shawna Follis
Postdoctoral Research Fellow, SCRDP/ Heart Disease Prevention
Bio Shawna Follis, PhD, MS, is a postdoctoral research fellow at the Stanford Prevention Research Center. Dr. Follis is a social epidemiologist researching social determinants of health, race/ethnic health disparities, body composition, and aging.
-
Prasanth Ganesan
Postdoctoral Research Fellow, Cardiovascular Medicine
Current Research and Scholarly Interests Signal processing, Pattern recognition, Atrial fibrillation, Arrhythmia Mapping
-
Jessica Grembi
Postdoctoral Research Fellow, Infectious Diseases
Bio Environmental enteric dysfunction (EED) affects 50-90% of children in low-income countries and is likely an important factor in child stunting as it impedes efficient nutrient uptake in the small intestine. EED is suspected to be the result of persistent exposure to enteric pathogens, although it has not been correlated with any specific pathogen. My research explores the interplay of gut microbiota, including enteric pathogens, and the host immune system with a focus on understanding EED so we can rationally design treatments and preventive measures.
-
Kenzo Ichimura
Postdoctoral Research Fellow, Pulmonary and Critical Care Medicine
Bio My long-term goal as a physician-scientist is to develop therapeutic strategies for right heart failure by elucidating its pathophysiology.
I graduated from Kyushu University, School of Medicine in Fukuoka, Japan in 2008. Following a residency program at Aso Iizuka Hospital, I finished fellowship in Emergency Medicine (1 year) and Cardiovascular Medicine (2 years). My clinical expertise is general cardiology, cardiac catheterization, echocardiography, and cardiac critical care.
After my clinical training, I started my research career working towards a Ph.D. under the mentorship of Dr. Kensuke Egashira. During my Ph.D., I published two papers focusing on the development of novel therapeutics for acute myocardial infarction and pulmonary arterial hypertension. Through this research experience, I developed skills in modeling and assessing cardiovascular disease in both small (rodents) and large animals (pigs)
In 2017, I was appointed as an Assistant Professor and attending physician in the Department of Emergency and Critical Care Medicine at Kyushu University Hospital. During this period, I learned that right heart failure was one of the most devastating conditions with no treatment options in patients with pulmonary hypertension, congenital heart disease, and patients on long-term mechanical ventricular assist devices. I also continued my research with a research grant funded by the Japanese Society for the Promotion of Science.
In 2019, I decided to further expand my research field into right heart failure and joined Dr. Edda Spiekerkoetter?s lab at Stanford University as a postdoctoral fellow. I am currently focusing on the role of BMPR2 in the cardiomyocytes, the structural changes in the right ventricle under pressure overload, and the development of right ventricle-targeting therapy in pulmonary hypertension. -
Gentaro Ikeda
Postdoctoral Research Fellow, Cardiovascular Medicine
Bio My long-term goal is to become a physician scientist and develop innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on my experience as a cardiologist for the past 5 years, I have become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including ?-blockers, ivabradine, and renin?angiotensin?aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, I moved to academia to conduct translational research. During my graduate training in the Egashira Lab, I focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. I obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. I realized the importance of translational research and the great potential of DDS to overcome many clinical problems. I developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. I published a first author paper and received academic awards for my novel science. Since becoming a postdoctoral fellow in the Yang Lab, I have continued to build upon my previous training in translational research. I am currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for the failing heart.
-
Nicholas Hedemann Juul
Clinical Scholar, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly Interests Molecular and cellular biology of the distal lung
High altitude medicine -
Abhinav Kaushik
Postdoctoral Research Fellow, Sean N Parker Center for Allergy & Asthma Research
Bio Abhinav Kaushik, PhD
Post-Doctoral Scholar
My current position at Stanford involves single cell Mass cytometry (CyTOF), gene expression and DNA methylation data analysis, as well as integrative analysis of single-cell datasets. I am working with a team to standardize the CyTOF data analysis pipeline using different statistical modeling approaches (linear or non-linear, Bayesian inference).
I have a strong experience in analyzing RNAseq, DNAseq and ChIP-seq data analysis. I am a programmer who loves to code with R, C# and perl. My keen interest includes application development for analyzing scientific data using different statistical approaches. However, my work is not restricted to one particular domain and sometimes includes in silico data analysis and algorithm development for solving both genomics and structural biology problems.
I have joined the Nadeau Laboratory at the Sean N. Parker Center for Allergy and Asthma Research at Stanford in July 2018. I received my PhD in Bioinformatics from the International Centre for Genetic Engineering and Biotechnology, India in 2017. Before joining the Nadeau Laboratory, I worked as a Visiting Researcher in the Pathogen Genomics laboratory at Kings Abdullah University of Science and Technology (KAUST), Saudi Arabia. -
Daniel Alexander King
Postdoctoral Medical Fellow, Oncology
Bio Daniel Alexander King, MD, PhD (Oncology Fellow)
Originally from Long Island, NY, Dan trained at Cold Spring Harbor Laboratory, the University of Michigan (BS), Wayne State University (MD), the National Human Genome Research Institute (HHMI Research Scholars Program), Cambridge University (PhD), and Columbia University (Internal Medicine Residency). He enjoys mutation hunting in large-scale genomic data. He was most recently involved in an exome sequencing study of 12,000 children with rare disease and their parents, in which he developed new computational tools to identify large genetic aberrations. His mutational spectrum of interest includes uniparental disomy, copy number alterations, and mosaicism. He plans to explore research opportunities riding the intersection of new technology & genomics, such as single cell DNA & RNA sequencing, and circulating tumor DNA.
During oncology fellowship he has developed a passion for pancreatic cancer and specializes in caring for patients with pancreatic cancer in clinic with renowned medical oncologist Dr George Fisher. During fellowship his pancreatic research interests span the spectrum of translational research in pancreatic cancer. Several recent accomplishments include: 1) the development of a pancreatic cancer-specific circulating tumor DNA assay, the development of a pancreatic cancer research database containing thousands of patients who presented to Stanford with pancreatic cancer over the last twenty years, and the development of a large +500 sample biobank consisting of blood samples from generous pancreatic cancer patient study participants.
Internal Staff Login